Table 2.
S. No. | Interventions | Structure | Mechanism | Disease Condition | References |
---|---|---|---|---|---|
1 | All-trans retinoic acid (ARTA/Retinoic acid) | Retinoic acid used for Mitochondria biogenesis and stimulated the retinoid X receptor-α (RXRα) to repair the mitochondrial respiratory chain defect | Lipid metabolism | [119, 148] | |
2 | KH176 | Intracellular reduction-oxidation-modulating compound used for the management of mitochondrial diseases | MELAS, LHON, Leigh, and other MDs | NCT02544217 & [149] | |
3 | Bezafibrate | Mitochondrial biogenesis and PPAR-α activation | Mitochondrial myopathy | [150] | |
4 | L-Arginine | Improvement in aerobic capacity and muscle metabolism | Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like syndrome (MELAS) | NCT01603446 & [151] | |
5 | Rapamycin | Improves motor endurance, muscle morphology, activation of autophagy via mTOR-dependent pathways and mitochondrial structure | Mitochondrial myopathy | [119, 152] | |
6 | Vatiquinone or EPI-743 |
EPI-743 works by enhancing the regulation of cellular energy metabolism by directing NADPH quinone oxidoreductase 1 (NQO1) | Leigh Syndrome and congenital respiratory chain diseases | [153] | |
7 | Idebenone | Idebenone stimulated the mitochondrial permeability transition pore (mPTP) | Leber Hereditary Optic Neuropathy (LHON) |
[154] | |
8 | Cysteamine bitartrate | Antioxidant properties by enhancing glutathione biosynthesis | Mitochondrial respiratory chain disease | [155] | |
9 | Omaveloxolone | Omaveloxolone is an Nrf2-inducer, reduces Inflammation, provides protective shelter to mitochondrial depolarization, promoting mitochondrial respiration and preventing cell death | Friedreich’s Ataxia (FRDA): an autosomal recessive neurodegenerative disorder | [156] | |
10 | Taurine | Neuroprotector by decreasing ER stress and antagonizing neurotransmitter receptors of GABAA, glycine and NMDA | Myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) | [157, 158] | |
11 | L-Carnitine | L-carnitine translocate the fatty acids into the mitochondrial compartment for β-oxidation. Role in carbohydrate metabolism like ketogenesis and glucogenesis. Elimination of toxic metabolites |
Mitochondrial dysfunction, Chronic progressive external ophthalmoplegia (CPEO) |
[159, 160] | |
12 | Tetracycline | Antiapoptotic, antiinflammation, antioxidation and improves fitness | Mitochondrial dysfunction and Leigh syndrome | [160, 161] | |
13 | Doxycycline | Prevents neuronal death and the accumulation of neuroimmune and inflammatory proteins | Mitochondrial dysfunction | [161] | |
14 | Pioglitazone | Peroxisome proliferator-activated receptor gamma (PPARγ) agonist | Pioglitazone improves lipopolysaccharide-induced behavioural loss, inflammation, white matter injury and mitochondrial dysfunction, inhibits diabetes-induced atrial mitochondrial oxidative stress and improves mitochondrial biogenesis, dynamics |
[162, 163] | |
15 | Sonlicromanol | Improves neuronal network dysfunction | Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) | [164] | |
16 | Oleanolic acid | Rescued mitochondrial ultra-structure anomalies and mitochondrial biogenesis | Cardiac aging | [165] |